Adoram Therapeutics
PrivateLast Round
Grant
May 5, 2025
Total Funding Raised
$1.3M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Adoram Therapeutics is a biotechnology company that develops allosteric modulators for the treatment of solid tumors and immune-based diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Adoram Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Adoram Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 5, 2025 | ||||
| Pre Seed | Feb 25, 2025 | ||||
| Seed | Oct 24, 2024 | ||||
| Accelerator | Feb 23, 2024 | ||||
| Grant | Apr 11, 2023 |
Key People
Founding team and executive leadership
Adoram Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Fongit | Seed, Pre Seed |
| Innosuisse | Grant |
| Venture Kick | Accelerator, Grant |
| Innosuisse | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 17, 2026
Monthly visitors increased 82% MoM.
- May 15, 2025
$1.27M grant received.
Adoram Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Adoram Therapeutics's valuation, stock price, and market status.